Concepedia

Loganathan Elangovan

LE

4

Publications

238

Citations

4

H-Index

2000

Active since

Affiliations

West Los Angeles College(Current)

University of Mississippi

University of California, Los Angeles

Charles R. Drew University of Medicine and Science

University of Tennessee Health Science Center

Loganathan Elangovan is an author at West Los Angeles College specializing in medicine, nephrology, and chronic kidney disease.

Top concepts

Publications per year

2000–2001

4

Publications

4

Intermittent doxercalciferol (1α-Hydroxyvitamin D2) therapy for secondary hyperparathyroidism

João Frazão, Loganathan Elangovan, Hla M. Maung et al. · American Journal of Kidney Diseases · 2000 · 129 citations

, , +5

Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1α-Hydroxyvitamin D2) in dialysis patients with secondary hyperparathyroidism: A sequential comparison

Hla M. Maung, Loganathan Elangovan, João Frazão et al. · American Journal of Kidney Diseases · 2001 · 75 citations

, , +8

Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1α-hydroxyvitamin D2) in dialysis patients with secondary hyperparathyroidism: A sequential comparison

Hla M. Maung, Loganathan Elangovan, João Frazão et al. · American Journal of Kidney Diseases · 2001 · 23 citations

, , +8

HEMO Equilibrated Kt/V Goals Are Difficult to Achieve in Large Male Patients

Loganathan Elangovan, Christian S. Shinaberger, Jeffrey A. Kraut et al. · ASAIO Journal · 2001 · 11 citations

, , +14

Rows per page

1–4 of 4